Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Next Vial vs The Edit

By GLP-1 ScorecardUpdated

Next VialFactor scores not reassessed.
Site position #376

Lower score

The EditFactor scores not reassessed.
Site position #117

Higher score

Score comparison

The Edit has the higher recorded score — 70.4/100 to 59.3/100.

The Edit grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The Edit holds one price at every dose, charges nothing to start, refunds in full if you are not approved, and then says none of its published policies actually govern.

Before you choose

Before comparing the headline prices, the Next Vial review and the The Edit review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Next Vial vs Tonik Wellness and Peak Wellness vs The Edit compare each of them with another graded program, and the list of alternatives to Next Vial ranks the programs closest to Next Vial on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the WellMedr review covers one graded close to these two, at 63.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueThe Edit +10
40
50
Dose & formulationThe Edit +20
52
72
Clinical oversightNext Vial +2
82
80
Labs & monitoringThe Edit +10
52
62
FulfillmentThe Edit +9
86
95
Contract termsThe Edit +30
55
85
Next Vial · top barThe Edit · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricNext VialThe Edit
WeighScore59.3/10070.4/100
GradeCC
Site position#376#117
Semaglutide$250/mo (compounded)$259/mo (standing rate, flat at every dose; $200 covers the first month only)
TirzepatideNot disclosed$349/mo (standing rate, flat at every dose; $300 covers the first month only)
Coverage49 statesAll 50 states (claimed; hedged in the same paragraph, no list published)
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Next Vial

Site position #376 · C

Factor scores not reassessed.

Strengths

  • LegitScript verified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
  • No membership fees — one all-in price covering consultation, medication, and shipping
  • Compounded semaglutide, tirzepatide, and microdose options available
  • Free rushed shipping; serves 49 states nationwide
  • Board-certified physician oversight with ongoing provider support

What to consider

  • Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
  • Compounded medications are not FDA-approved
  • Labs and nutritional coaching not disclosed
  • Microdose pricing not published on product page
  • Alaska not listed among served states
The Edit

Site position #117 · C

Factor scores not reassessed.

Strengths

  • The price is flat at every dose with no titration ladder, so the figure a reader sees is the figure at maintenance
  • Nothing is charged and no card is taken to begin, and a full refund applies if a clinician does not approve treatment
  • Names its medical director with an NPI number and the medical practice behind him, and names a dispensing pharmacy
  • Prescription medication, injection supplies, the clinician visit and ongoing care are itemized as included, with no membership fee
  • A separate hormone menu is priced beside the GLP-1 lines

What to consider

  • $200 and $300 are first-order promotional prices printed larger than the struck standing rates of $259 and $349, and the promotion carries no end date and no code
  • The published cancellation and refund policies say the Membership Agreement controls where they differ, and that nothing on the public site is binding — so the terms a reader can read are not the terms that apply
  • Two-day shipping is transit time only; the site's own shipping policy states an average of 4 to 12 business days from prescription
  • “Available in all 50 U.S. states” is hedged in the same paragraph and no state list is published anywhere
  • The three- and six-month figures are one charge, not a monthly rate, and the per-month numbers beside them are arithmetic rather than billing
  • The named pharmacy is described as one member of a plural pharmacy network whose other members are not named
  • No compounding class is stated, and whether a separate visit fee is ever charged is not answered

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard